Eli Lilly and Company Statistics

Total Valuation

Eli Lilly and Company has a market cap or net worth of EUR 663.66 billion. The enterprise value is 689.81 billion.

Market Cap	663.66B
Enterprise Value	689.81B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Feb 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	898.40M

Valuation Ratios

The trailing PE ratio is 88.44.

PE Ratio	88.44
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	382.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.93, with an EV/FCF ratio of 549.63.

EV / Earnings	91.92
EV / Sales	17.58
EV / EBITDA	42.93
EV / EBIT	48.23
EV / FCF	549.63

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 2.18.

Current Ratio	1.27
Quick Ratio	0.63
Debt / Equity	2.18
Debt / EBITDA	1.87
Debt / FCF	22.31
Interest Coverage	21.46

Financial Efficiency

Return on equity (ROE) is 65.32% and return on invested capital (ROIC) is 24.12%.

Return on Equity (ROE)	65.32%
Return on Assets (ROA)	13.95%
Return on Capital (ROIC)	24.12%
Revenue Per Employee	852,047
Profits Per Employee	174,522
Employee Count	43,000
Asset Turnover	0.61
Inventory Turnover	1.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.05% in the last 52 weeks. The beta is 0.42, so Eli Lilly and Company's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+44.05%
50-Day Moving Average	770.53
200-Day Moving Average	777.17
Relative Strength Index (RSI)	52.24
Average Volume (20 Days)	4,324

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.55

Income Statement

In the last 12 months, Eli Lilly and Company had revenue of EUR 36.64 billion and earned 7.50 billion in profits. Earnings per share was 8.29.

Revenue	36.64B
Gross Profit	29.64B
Operating Income	13.36B
Pretax Income	9.10B
Net Income	7.50B
EBITDA	14.85B
EBIT	13.36B
Earnings Per Share (EPS)	8.29

Full Income Statement

Balance Sheet

The company has 3.15 billion in cash and 28.00 billion in debt, giving a net cash position of -24.35 billion.

Cash & Cash Equivalents	3.15B
Total Debt	28.00B
Net Cash	-24.35B
Net Cash Per Share	n/a
Equity (Book Value)	12.84B
Book Value Per Share	14.19
Working Capital	6.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.41 billion and capital expenditures -4.15 billion, giving a free cash flow of 1.26 billion.

Operating Cash Flow	5.41B
Capital Expenditures	-4.15B
Free Cash Flow	1.26B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 80.91%, with operating and profit margins of 36.46% and 20.48%.

Gross Margin	80.91%
Operating Margin	36.46%
Pretax Margin	24.84%
Profit Margin	20.48%
EBITDA Margin	40.54%
EBIT Margin	36.46%
FCF Margin	3.43%

Dividends & Yields

This stock pays an annual dividend of 4.82, which amounts to a dividend yield of 0.63%.

Dividend Per Share	4.82
Dividend Yield	0.63%
Dividend Growth (YoY)	15.46%
Years of Dividend Growth	11
Payout Ratio	54.12%
Buyback Yield	-0.08%
Shareholder Yield	0.55%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Eli Lilly and Company has an Altman Z-Score of 8.15.

Altman Z-Score	8.15
Piotroski F-Score	n/a